Similarly, in NSCLC patients, higher levels of Exo-PD-L1, rather than soluble PD-L1, were reported to be interrelated to larger tumor size, positive lymph node status, distant metastasis, and late TNM staging [136]. This evidence concerns the gene CD274 and neoplasm.